These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24091000)

  • 41. Evolution of antimicrobial susceptibility patterns of aerobic and facultative gram-negative bacilli causing intra-abdominal infections: results from the SMART studies 2003-2007.
    Guembe M; Cercenado E; Alcalá L; Marín M; Insa R; Bouza E
    Rev Esp Quimioter; 2008 Sep; 21(3):166-73. PubMed ID: 18792817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
    Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
    J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.
    Farajnia S; Alikhani MY; Ghotaslou R; Naghili B; Nakhlband A
    Int J Infect Dis; 2009 Mar; 13(2):140-4. PubMed ID: 18703368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia.
    Sader HS; Castanheira M; Flamm RK; Mendes RE; Farrell DJ; Jones RN
    Int J Antimicrob Agents; 2015 Jul; 46(1):53-9. PubMed ID: 25956844
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactams.
    Roland RK; Mendes RE; Silbert S; Bolsoni AP; Sader HS
    Braz J Infect Dis; 2000 Oct; 4(5):226-35. PubMed ID: 11063554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
    Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H
    Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro activity of tigecycline and comparators against Gram-negative pathogens isolated from blood in Europe (2004-2009).
    Andrasevic AT; Dowzicky MJ
    Int J Antimicrob Agents; 2012 Feb; 39(2):115-23. PubMed ID: 22189391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequency of isolation and antimicrobial susceptibility of bacteria isolated from bloodstream infections at Children's Medical Center, Tehran, Iran, 1996-2000.
    Mamishi S; Pourakbari B; Ashtiani MH; Hashemi FB
    Int J Antimicrob Agents; 2005 Nov; 26(5):373-9. PubMed ID: 16213124
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frequency of Gram-negative bacterial pathogens in bloodstream infections and their resistance to antibiotics in the Czech Republic.
    Cermák P; Kolár M; Látal T
    Int J Antimicrob Agents; 2004 Apr; 23(4):401-4. PubMed ID: 15081092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro activity of fosfomycin tromethamine against extended spectrum beta-lactamase producing urinary tract bacteria.
    Khan IU; Mirza IA; Ikram A; Ali S; Hussain A; Ghafoor T
    J Coll Physicians Surg Pak; 2014 Dec; 24(12):914-7. PubMed ID: 25523727
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial susceptibility of Gram-negative bacteria causing intra-abdominal infections in China: SMART China 2011.
    Zhang H; Yang Q; Xiao M; Chen M; Badal RE; Xu Y
    Chin Med J (Engl); 2014; 127(13):2429-33. PubMed ID: 24985578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011).
    Sader HS; Flamm RK; Jones RN
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):217-21. PubMed ID: 23522845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
    Ko WC; Hsueh PR
    J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010.
    Sievert DM; Ricks P; Edwards JR; Schneider A; Patel J; Srinivasan A; Kallen A; Limbago B; Fridkin S;
    Infect Control Hosp Epidemiol; 2013 Jan; 34(1):1-14. PubMed ID: 23221186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Avibactam reverts the ceftazidime MIC90 of European Gram-negative bacterial clinical isolates to the epidemiological cut-off value.
    Flamm RK; Stone GG; Sader HS; Jones RN; Nichols WW
    J Chemother; 2014 Dec; 26(6):333-8. PubMed ID: 24125508
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009.
    Zilberberg MD; Shorr AF
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):940-6. PubMed ID: 23917908
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Etiology, extended-spectrum β-lactamase rates and antimicrobial susceptibility of gram-negative bacilli causing intra-abdominal infections in patients in general pediatric and pediatric intensive care units--global data from the Study for Monitoring Antimicrobial Resistance Trends 2008 to 2010.
    Badal RE; Bouchillon SK; Lob SH; Hackel MA; Hawser SP; Hoban DJ
    Pediatr Infect Dis J; 2013 Jun; 32(6):636-40. PubMed ID: 23838732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011.
    Bouchillon SK; Badal RE; Hoban DJ; Hawser SP
    Clin Ther; 2013 Jun; 35(6):872-7. PubMed ID: 23623624
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bacteriologic profile and antibiogram of blood culture isolates from a children's hospital in Kabul.
    Tariq TM
    J Coll Physicians Surg Pak; 2014 Jun; 24(6):396-399. PubMed ID: 24953929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.